(2024)
Inflamed immune phenotype predicts favorable clinical outcomes of immune checkpoint inhibitor therapy across multiple cancer types.
JOURNAL FOR IMMUNOTHERAPY OF CANCER.
(2024)
PD-L1 expression in resected lung adenocarcinoma: prevalence and prognostic significance in relation to the IASLC grading system.
HISTOPATHOLOGY.
(2024)
c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer.
BREAST CANCER RESEARCH.
(2024)
Trends and Clinical Characteristics of Next-Generation Sequencing-Based Genetic Panel Tests: An Analysis of Korean Nationwide Claims Data.
CANCER RESEARCH AND TREATMENT.
56,
1
(2023)
Clinical Course of Patients With Mediastinal Lymph Node Tuberculosis and Risk Factors for Paradoxical Responses.
JOURNAL OF KOREAN MEDICAL SCIENCE.
38,
47
(2023)
Establishing molecular pathology curriculum for pathology trainees and continued medical education: a collaborative work from the Molecular Pathology Study Group of the Korean Society of Pathologists.
Journal of Pathology and Translational Medicine.
57,
5
(2023)
Longitudinal Monitoring of Circulating Tumor DNA From Plasma in Patients With Curative Resected Stages I to IIIA EGFR-Mutant Non–Small Cell Lung Cancer.
JOURNAL OF THORACIC ONCOLOGY.
18,
9
(2023)
Prognostic Significance of Volumetric Parameters Based on FDG PET/CT in Patients with Lung Adenocarcinoma Undergoing Curative Surgery.
CANCERS.
15,
17
(2023)
NTRK Fusion in a Cohort of BRAF p. V600E Wild-Type Papillary Thyroid Carcinomas.
MODERN PATHOLOGY.
36,
8
(2023)
Longitudinal multi-omics study of palbociclib resistance in HR-positive/HER2-negative metastatic breast cancer.
GENOME MEDICINE.
15,
1
(2023)
Programmed Death-Ligand 1 Copy Number Alteration as an Adjunct Biomarker of Response to Immunotherapy in Advanced NSCLC.
JOURNAL OF THORACIC ONCOLOGY.
18,
7
(2023)
Whole-Section Landscape Analysis of Molecular Subtypes in Curatively Resected Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Significance.
MODERN PATHOLOGY.
36,
7
(2023)
Trends in Survival Rates of Non-Small Cell Lung Cancer with Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020.
JAMA NETWORK OPEN.
6,
3
(2023)
Different prognostic role of EGFR mutation according to the IASLC histological grade in patients with resected early-stage lung adenocarcinoma.
HISTOPATHOLOGY.
83,
2
(2022)
Usage of epidermal growth factor mutation testing and impact on treatment patterns in non-small cell lung cancer: An international observational study.
LUNG CANCER.
(2022)
The Ring Study: an international comparison of PD-L1 diagnostic assays and their interpretation in non-small cell lung cancer, head and neck squamous cell cancer and urothelial cancer..
PATHOLOGY.
(2022)
Clinical, Pathologic, and Molecular Prognostic Factors in Patients with Early-Stage EGFR-Mutant NSCLC br.
CLINICAL CANCER RESEARCH.
28,
19
(2022)
Cancer-Specific Sequences in the Diagnosis and Treatment of NUT Carcinoma..
CANCER RESEARCH AND TREATMENT.
(2022)
Comprehensive Molecular Characterization of Soft Tissue Sarcoma for Prediction
of Pazopanib-Based Treatment Response..
CANCER RESEARCH AND TREATMENT.
(2022)
Response Rate and Safety of a Neoadjuvant Pertuzumab, Atezolizumab, Docetaxel, and Trastuzumab Regimen for Patients with ERBB2 -Positive Stage II/III Breast Cancer: The Neo-PATH Phase 2 Nonrandomized Clinical Trial.
JAMA ONCOLOGY.
8,
9
학술회의논문
(2011)
Comparision of peptide nucleic acid(PNA)-mediated PCR clamping, COLD-PCR, and direct sequencing in detection of PIK3CA, BRAF and KRAS mutations in colorectal cancers.
Association of Molecular Pathology.
미국
(2011)
IDH1 mutation is a favorable prognostic factor for type 2 gliomatosis recebri.
Association of Molecular Pathology.
미국
(2011)
Testing Practices for EGFR and KRAS in Advanced Non-Small Cell Lung Cancer in a Comprehensive Cancer Care Setting in Korea.
European Society for Medical Oncology.
스웨덴
(2011)
Detection of MDM2 and CDK4 by Fluorescence in Situ Hybridization, Immunohistochemistry and Real-time PCR in Liposarcoma: Prognositic Significance based on the Molecular Diagnosis.
USCAP.
미국
